Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Robertson

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Melanoma Research|December 1, 2018
Loss of miR-155 upregulates WEE1 in metastatic melanomaJulie A DiSano, Ian Huffnagle, Raghavendra Gowda, et al.
Pharmacological Research|April 3, 2024
Pharmacological agents targeting drug-tolerant persister cells in cancerYu-Chi Chen, Krishne Gowda, Shantu Amin, et al.
Pigment Cell & Melanoma Research|January 13, 2012
Targeting sphingosine kinase-1 to inhibit melanomaSubbaRao V Madhunapantula, Jeremy Hengst, Raghavendra Gowda, et al.
The Journal of Investigative Dermatology|October 16, 2004
Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasmsChristopher J Miller, Mitchell Cheung, Arati Sharma, et al.
Pigment Cell & Melanoma Research|July 8, 2017
Targeting cholesterol transport in circulating melanoma cells to inhibit metastasisYu-Chi Chen, Raghavendra Gowda, Raymond K Newswanger, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Novel Pan-ALDH Inhibitor KS100 Effectively Targets ALDH+/CD138⁻ Stem-like Cells to Overcome Relapse in Multiple MyelomaRobert Chitren, Krishne Gowda, Shantu Amin, et al.
Cancer Research|March 23, 2005
Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumorsArati Sharma, Nishit R Trivedi, Melissa A Zimmerman, et al.
Journal of Medicinal Chemistry|December 5, 2008
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanatesArun K Sharma, Arati Sharma, Dhimant Desai, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 11, 2018
Nanoliposomal delivery of cytosolic phospholipase A<sub>2</sub> inhibitor arachidonyl trimethyl ketone for melanoma treatmentRaghavendra Gowda, Saketh S Dinavahi, Soumya Iyer, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 9, 2014
Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3pDouglas F Dluzen, Dongxiao Sun, Anna C Salzberg, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Melanoma Research|December 1, 2018
Loss of miR-155 upregulates WEE1 in metastatic melanomaJulie A DiSano, Ian Huffnagle, Raghavendra Gowda, et al.
Pharmacological Research|April 3, 2024
Pharmacological agents targeting drug-tolerant persister cells in cancerYu-Chi Chen, Krishne Gowda, Shantu Amin, et al.
Pigment Cell & Melanoma Research|January 13, 2012
Targeting sphingosine kinase-1 to inhibit melanomaSubbaRao V Madhunapantula, Jeremy Hengst, Raghavendra Gowda, et al.
The Journal of Investigative Dermatology|October 16, 2004
Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasmsChristopher J Miller, Mitchell Cheung, Arati Sharma, et al.
Pigment Cell & Melanoma Research|July 8, 2017
Targeting cholesterol transport in circulating melanoma cells to inhibit metastasisYu-Chi Chen, Raghavendra Gowda, Raymond K Newswanger, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Novel Pan-ALDH Inhibitor KS100 Effectively Targets ALDH+/CD138⁻ Stem-like Cells to Overcome Relapse in Multiple MyelomaRobert Chitren, Krishne Gowda, Shantu Amin, et al.
Cancer Research|March 23, 2005
Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumorsArati Sharma, Nishit R Trivedi, Melissa A Zimmerman, et al.
Journal of Medicinal Chemistry|December 5, 2008
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanatesArun K Sharma, Arati Sharma, Dhimant Desai, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 11, 2018
Nanoliposomal delivery of cytosolic phospholipase A<sub>2</sub> inhibitor arachidonyl trimethyl ketone for melanoma treatmentRaghavendra Gowda, Saketh S Dinavahi, Soumya Iyer, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 9, 2014
Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3pDouglas F Dluzen, Dongxiao Sun, Anna C Salzberg, et al.
Pageof 12